BBIXF (Bonus BioGroup) LT-Debt-to-Total-Asset: 0.46 (As of Dec. 2025)


BBIXF Bonus BioGroup Ltd BBIXF
30 GF Score
Price $0.11
! 3 Warning Signs
View Full Analysis

What is Bonus BioGroup LT-Debt-to-Total-Asset?

Bonus BioGroup BBIXF 30 LT-Debt-to-Total-Asset is 0.46 as of Dec. 2025. GuruFocus rates BBIXF with a GF Score™ of 30/100. The stock has 3 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Bonus BioGroup's long-term debt to total assests ratio for the quarter that ended in Dec. 2025 was 0.46.

Bonus BioGroup's long-term debt to total assets ratio increased from Dec. 2024 (0.37) to Dec. 2025 (0.46). It may suggest that Bonus BioGroup is progressively becoming more dependent on debt to grow their business.

Bonus BioGroup  (OTCPK:BBIXF) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Bonus BioGroup LT-Debt-to-Total-Asset Related Terms

Bonus BioGroup LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Bonus BioGroup's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bonus BioGroup LT-Debt-to-Total-Asset Chart

Bonus BioGroup Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.14 0.22 0.37 0.46

Bonus BioGroup Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.29 0.37 0.46 0.46
BBIXF
30GF Score
Bonus BioGroup Ltd BBIXF
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bonus BioGroup LT-Debt-to-Total-Asset Calculation

Bonus BioGroup's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )/Total Assets (A: Dec. 2025 )
=2.362/5.128
=

Bonus BioGroup's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (Q: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2025 )/Total Assets (Q: Dec. 2025 )
=2.362/5.128
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.46 mean?
Bonus BioGroup (BBIXF) has a LT-Debt-to-Total-Asset of 0.46 as of Dec. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Bonus BioGroup and its competitors.
Is Bonus BioGroup's LT-Debt-to-Total-Asset too high?
Bonus BioGroup's current LT-Debt-to-Total-Asset is 0.46. Overall, Bonus BioGroup has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Bonus BioGroup's LT-Debt-to-Total-Asset compare to VRTX and REGN?
Bonus BioGroup's LT-Debt-to-Total-Asset of 0.46 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Biotechnology company?
A good LT-Debt-to-Total-Asset depends on the Biotechnology industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Bonus BioGroup and its competitors. Bonus BioGroup's current LT-Debt-to-Total-Asset is 0.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonus BioGroup stock overvalued right now?
Bonus BioGroup (BBIXF) has a current LT-Debt-to-Total-Asset of 0.46. The current LT-Debt-to-Total-Asset is 0.46. Bonus BioGroup's overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Bonus BioGroup (BBIXF), the current LT-Debt-to-Total-Asset is 0.46 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bonus BioGroup Business Description

Other Exchanges BONS:Israel
Address Matam Advanced, Technology Park, P.O.B 15143, Haifa, ISR, 31905
Bonus BioGroup Ltd is an clinical-stage biotechnology company developing next-generation therapies for a variety of indications in the regenerative medicine field. Its products products, BonoFill and MesenCure.
30GF Score

Get the complete analysis for BBIXF

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.11
Price